受强制性开放获取政策约束的文章 - Pasquale Niscola了解详情
无法在其他位置公开访问的文章：1 篇
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation …
MD Bo, MI Del Principe, F Pozzo, D Ragusa, P Bulian, D Rossi, G Capelli, ...
Annals of hematology 93, 1765-1774, 2014
强制性开放获取政策： Government of Italy
可在其他位置公开访问的文章：10 篇
Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the I talian network on secondary leukemias
L Fianchi, L Pagano, A Piciocchi, A Candoni, G Gaidano, M Breccia, ...
American journal of hematology 90 (5), E80-E85, 2015
强制性开放获取政策： Government of Italy
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)
GA Abel, F Efficace, RJ Buckstein, S Tinsley, JG Jurcic, Y Martins, ...
Haematologica 101 (6), 781, 2016
强制性开放获取政策： Canadian Cancer Society
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
F Efficace, F Cottone, LB Oswald, D Cella, A Patriarca, P Niscola, ...
Leukemia 34 (9), 2451-2459, 2020
强制性开放获取政策： US National Institutes of Health
Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
P Musto, L Maurillo, V Simeon, A Poloni, C Finelli, E Balleari, A Ricco, ...
British journal of haematology 177 (5), 741-750, 2017
强制性开放获取政策： Government of Italy
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience
G Calabretto, E Attardi, A Teramo, V Trimarco, S Carraro, S Mossuto, ...
Leukemia 36 (7), 1947-1950, 2022
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Myelodysplastic syndromes with del (5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
C Gurnari, A Piciocchi, S Soddu, F Bonanni, E Scalzulli, P Niscola, ...
Blood Cancer Journal 12 (9), 132, 2022
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
Ascorbate plus buformin in AML: a metabolic targeted treatment
C Banella, G Catalano, S Travaglini, E Pelosi, T Ottone, A Zaza, ...
Cancers 14 (10), 2565, 2022
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: Results from the multicenter FISM BIOFER study
D Cilloni, S Ravera, C Calabrese, V Gaidano, P Niscola, E Balleari, ...
Scientific Reports 10 (1), 9156, 2020
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy: a case report
L Wang, N Lin
Medicine 100 (6), e24703, 2021
强制性开放获取政策： 国家自然科学基金委员会
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. Cancers 2022, 14, 2565
C Banella, G Catalano, S Travaglini, E Pelosi, T Ottone, A Zaza, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
强制性开放获取政策： Government of Italy, AIRC Foundation for Cancer Research in Italy
出版信息和资助信息由计算机程序自动确定